Quest Diagnostics Revenue 2010-2024 | DGX

Quest Diagnostics annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Quest Diagnostics revenue for the quarter ending March 31, 2024 was $2.366B, a 1.5% increase year-over-year.
  • Quest Diagnostics revenue for the twelve months ending March 31, 2024 was $9.287B, a 3.29% decline year-over-year.
  • Quest Diagnostics annual revenue for 2023 was $9.252B, a 6.38% decline from 2022.
  • Quest Diagnostics annual revenue for 2022 was $9.883B, a 8.39% decline from 2021.
  • Quest Diagnostics annual revenue for 2021 was $10.788B, a 14.32% increase from 2020.
Quest Diagnostics Annual Revenue
(Millions of US $)
2023 $9,252
2022 $9,883
2021 $10,788
2020 $9,437
2019 $7,726
2018 $7,531
2017 $7,402
2016 $7,214
2015 $7,493
2014 $7,435
2013 $7,146
2012 $7,383
2011 $7,392
2010 $7,260
2009 $7,455
Quest Diagnostics Quarterly Revenue
(Millions of US $)
2024-03-31 $2,366
2023-12-31 $2,288
2023-09-30 $2,295
2023-06-30 $2,338
2023-03-31 $2,331
2022-12-31 $2,333
2022-09-30 $2,486
2022-06-30 $2,453
2022-03-31 $2,611
2021-12-31 $2,744
2021-09-30 $2,774
2021-06-30 $2,550
2021-03-31 $2,720
2020-12-31 $3,002
2020-09-30 $2,786
2020-06-30 $1,827
2020-03-31 $1,822
2019-12-31 $1,926
2019-09-30 $1,956
2019-06-30 $1,953
2019-03-31 $1,891
2018-12-31 $1,839
2018-09-30 $1,889
2018-06-30 $1,919
2018-03-31 $1,884
2017-12-31 $1,865
2017-09-30 $1,856
2017-06-30 $1,864
2017-03-31 $1,817
2016-12-31 $1,560
2016-09-30 $1,885
2016-06-30 $1,906
2016-03-31 $1,863
2015-12-31 $1,849
2015-09-30 $1,880
2015-06-30 $1,925
2015-03-31 $1,839
2014-12-31 $1,883
2014-09-30 $1,904
2014-06-30 $1,902
2014-03-31 $1,746
2013-12-31 $1,756
2013-09-30 $1,788
2013-06-30 $1,815
2013-03-31 $1,787
2012-12-31 $1,774
2012-09-30 $1,822
2012-06-30 $1,878
2012-03-31 $1,909
2011-12-31 $1,761
2011-09-30 $1,906
2011-06-30 $1,903
2011-03-31 $1,822
2010-12-31 $1,715
2010-09-30 $1,865
2010-06-30 $1,875
2010-03-31 $1,806
2009-12-31 $1,848
2009-09-30 $1,897
2009-06-30 $1,902
2009-03-31 $1,808
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $15.353B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.002B 10.28
DaVita (DVA) United States $12.299B 15.28
Elanco Animal Health (ELAN) United States $8.994B 23.33
Encompass Health (EHC) United States $8.506B 21.77
Chemed (CHE) United States $8.076B 25.03
Option Care Health (OPCH) United States $4.839B 18.32
RadNet (RDNT) United States $4.232B 88.12
Amedisys (AMED) United States $2.993B 21.20
Astrana Health (ASTH) United States $2.272B 30.72
LifeStance Health (LFST) United States $2.018B 0.00
Addus HomeCare (ADUS) United States $1.914B 27.38
U.S Physical Therapy (USPH) United States $1.400B 37.46
Pennant (PNTG) United States $0.662B 34.98
Aveanna Healthcare Holdings (AVAH) United States $0.491B 0.00
Atai Life Sciences (ATAI) Germany $0.223B 0.00
Daxor (DXR) United States $0.042B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Novo Integrated Sciences (NVOS) United States $0.014B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00